MLKL and Behcet disease: In this study, by exploring the relationship between the immunity regulation of BD with the gut microbiota, we identified IPA, a microbial metabolite of Trp, that inhibits the necroptosis of the intestinal epithelium through RIPK1/3-MLKL pathway and promotes mucosal healing.